More articles from Volume 44, Issue 1, 2015
HLORINIŠUĆA AKTIVNOST SERUMSKE MIJELOPEROKSIDAZE U AKUTNOM ISHEMIČNOM MOŽDANOM UDARU
KVANTITATIVNA ANALIZA MAKROFAGA U GINGIVITISU I PARODONTOPATIJI
Is hypertension, in children who are on chronic hemodialysis therapy, crucial for the development of cardiac hypertrophy?
LEČENJE INFERTILNIH I SUBFERTILNIH MUŠKARACA SA VARIKOKELOM MINIMALNO INVAZIVNIM HIRURŠKIM METODOM
HISTOLOŠKO-CITOLOŠKA KORELACIJA NALAZA I POUZDANOST PAPANICOLAU TESTA U OTKRIVANJU PREMALIGNIH I MALIGNIH PROMENA NA GRLIĆU MATERICE
COMPARISON OF DIFFERENT DEFINITIONS OF THE METABOLIC SYNDROME IN RELATION TO CORONARY ARTERY DISEASE IN HIGH RISK SERBIAN POPULATION
,
I. Velickovic
,
J. Milin-Lazovic
,
E. Nestorovic
,
A. Cirkovic
,
M. Savic
,
N. Stojkovic
,
S. Masic
N. Milic
Published: 01.12.2014.
Volume 44, Issue 1 (2015)
pp. 115-121;
Abstract
Keywords
References
1.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;2486–97.
2.
Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;539–53.
3.
Grundy S, Brewer H, Cleeman J, Smith S, Lenfant C. Definition of metabolic syndrome. Circulation. 2004;433–8.
4.
Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005;2735–52.
5.
Federation I. The IDF consensus worldwide definition of the metabolic syndrom. :1–14.
6.
Alberti K, Zimmet P, Shaw J. The metabolic syndrome -a new worldwide definition. Lancet. 2005;1059–62.
7.
Nilsson P, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects a population-based study comparing three different definitions. Diabet Med. 2007;464–72.
8.
Saely C, Koch L, Schmid F, Marte T, Aczel S, Langer P, et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care. 2006;901–7.
9.
Tong P, Kong A, So W, Yang X, Ho C, Ma R, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program’s Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care. 2007;(5):1206–11.
10.
Lawlor D, Smith G, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women’s Heart and Health Study. Diabetologia. 2006;41–8.
11.
Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006;2837–46.
12.
Sattar N, Gaw A, Scherbakova O, Ford I, Reilly O, Haffner D, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;414–9.
13.
Koutsovasilis A, Protopsaltis J, Triposkiadis F, Kokkoris S, Milionis H, Zairis M, et al. Comparative Performance of Three Metabolic Syndrome Definitions in the Prediction of Acute Coronary Syndrome. Inter Med. 2009;179–87.
14.
Katzmarzyk P, Janssen I, Ross R, Church T, Blair S. The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care. 2006;404–9.
15.
Parapid B, Ostojic M, Lalic N, Micic D, Damjanovic S, Bubanja D, et al. Risk factors clustering within the metabolic syndrome: a pattern or by chance? Hellenic J Cardiol. 2014;(2):92–100.
16.
Obesity: Preventing and Managin the Global epidemic. 1998;
17.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. JAMA. 2003;(19):2560–72.
18.
Hwang Y, Jee J, Oh E, Choi Y, Lee M, Kim K, et al. Metabolic syndrome as a predictor of cardiovascular diseases and type 2 diabetes in Koreans. Int J Cardiol. 2009;(3):313–21.
19.
Wang C, Hou X, Bao Y, Pan J, Zuo Y, Zhong W, et al. The metabolic syndrome increased risk of cardiovascular events in Chinese-A community based study. Int J Cardiol. 2008;
20.
Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation. 1995;831–7.
21.
Willerson J, Ridker P. Inflammation as a cardiovascular risk factor. Circulation. 2004;I2-10.
22.
Lorenzo C, Williams K, Hunt K, Haffner S. The National Cholesterol Education Program Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007;8–13.
23.
Balkau B, Deanfield J, Després J, Bassan J, Fox K, Smith S. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients in 63 countries. Circulation. 2007;(17):1942–51.
24.
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi M, Commerford P, et al. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;1640–9.
25.
Cote M, Mauriege P, Bergeron J. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab. 2005;1434–9.
26.
Ford E. Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S. Diabetes Care. 2005;2745–9.
27.
Lorenzo C, Serrano-Rios M, Martinez-Larrad M, Gabriel R, Williams K, Gomez-Gerique J, et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res. 2003;1480–7.
28.
Sundstrom J, Riserus U, Byberg L, Zethelius B, Lithell H, Lind L. Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study. BMJ. 2006;878–82.
29.
Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds R, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;1398–405.
30.
Woodward M, Tunstall-Pedoe H. The metabolic syndrome is not a sensible tool for predicting the risk of coronary heart disease. Eur J Cardiovasc Prev Rehabil. 2009;(2):210–4.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
